tiprankstipranks
Fineotex Chemical Limited (IN:FCL)
:FCL
India Market
Want to see IN:FCL full AI Analyst Report?

Fineotex Chemical Limited (FCL) AI Stock Analysis

6 Followers

Top Page

IN:FCL

Fineotex Chemical Limited

(FCL)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - Gpt-5.6Sol)
Rating:69Neutral
Price Target:
₹62.00
▲(27.89% Upside)
Action:Downgraded
Date:09/08/26
Score is driven by strong fundamentals (profitability and a low-leverage balance sheet) but is meaningfully held back by weakened cash generation (negative operating and free cash flow in FY2026). Technicals are supportive with strong trend strength, though overbought signals add pullback risk. Valuation is the largest constraint due to the high P/E and low dividend yield.
Positive Factors
Strong Revenue Growth
The company has demonstrated strong revenue expansion over the cycle, indicating broad demand for its specialty textile chemicals across processing applications. This growth can support operating scale, customer penetration, and continued investment in higher-value products over the next several quarters.
Negative Factors
Weak Cash Conversion
Negative operating and free cash flow despite strong reported profits raises concern about cash conversion and the amount of capital absorbed by growth or working capital. If sustained, this could reduce internally funded investment capacity and increase reliance on balance-sheet flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
The company has demonstrated strong revenue expansion over the cycle, indicating broad demand for its specialty textile chemicals across processing applications. This growth can support operating scale, customer penetration, and continued investment in higher-value products over the next several quarters.
Read all positive factors

Fineotex Chemical Limited (FCL) vs. iShares MSCI India ETF (INDA)

Fineotex Chemical Limited Business Overview & Revenue Model

Company Description
Founded in 1979 and based in Mumbai, India, Fineotex Chemical Limited is a global manufacturer and distributor of a broad spectrum of specialty and auxiliary chemicals. The company develops tailored chemical solutions for the textile industry, cov...
How the Company Makes Money
FCL primarily makes money by selling specialty textile chemicals to industrial customers (e.g., textile processors, dyeing and finishing units, and garment-related processing facilities). Revenue is generated from (i) product sales of chemical for...

Fineotex Chemical Limited Financial Statement Overview

Summary
Strong profitability and revenue growth over the cycle, supported by a conservatively leveraged balance sheet and solid ROE. The main drag is cash conversion: operating cash flow and free cash flow turned negative in FY2026, raising near-term working-capital and reinvestment discipline risk despite strong reported earnings.
Income Statement
84
Very Positive
Balance Sheet
91
Very Positive
Cash Flow
52
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue10.12B7.72B5.33B5.69B5.17B3.67B
Gross Profit2.76B2.01B2.06B2.17B1.78B1.30B
EBITDA1.96B1.68B1.52B1.65B1.13B767.24M
Net Income1.22B1.09B1.08B1.20B883.16M551.74M
Balance Sheet
Total Assets0.0011.59B8.15B5.48B4.22B3.39B
Cash, Cash Equivalents and Short-Term Investments732.33M732.33M330.01M735.06M611.90M308.35M
Total Debt0.0081.96M2.17M51.90M72.80M19.08M
Total Liabilities-9.40B2.19B757.59M945.90M659.02M700.96M
Stockholders Equity9.40B8.82B7.31B4.47B3.49B2.62B
Cash Flow
Free Cash Flow81.22M-476.20M-73.46M494.76M887.62M-91.37M
Operating Cash Flow200.95M-222.29M693.34M973.81M1.08B133.75M
Investing Cash Flow-51.66M987.46M-2.73B-468.50M-1.03B-7.44M
Financing Cash Flow-49.37M-611.54M1.76B-239.11M-64.39M-56.59M

Fineotex Chemical Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price48.48
Price Trends
50DMA
42.31
Positive
100DMA
37.77
Positive
200DMA
30.57
Positive
Market Momentum
MACD
2.97
Negative
RSI
73.32
Negative
STOCH
69.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Positive. The current price of 48.48 is above the 20-day moving average (MA) of 47.31, above the 50-day MA of 42.31, and above the 200-day MA of 30.57, indicating a bullish trend. The MACD of 2.97 indicates Negative momentum. The RSI at 73.32 is Negative, neither overbought nor oversold. The STOCH value of 69.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹59.98B43.080.23%91.44%19.67%
63
Neutral
₹81.88B39.760.43%11.08%34.10%
61
Neutral
₹97.45B133.320.77%90.13%-6.80%
57
Neutral
₹25.53B16.940.11%19.47%11.49%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
₹19.57B28.530.13%27.57%135.05%
42
Neutral
₹19.81B396.190.47%8.40%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FCL
Fineotex Chemical Limited
56.66
33.27
142.23%
IN:BALAMINES
Balaji Amines Limited
2,565.80
1,074.59
72.06%
IN:BODALCHEM
Bodal Chemicals Limited
170.90
105.19
160.08%
IN:CAMLINFINE
Camlin Fine Sciences Limited
101.85
-106.05
-51.01%
IN:ROSSARI
Rossari Biotech Ltd
458.05
-157.20
-25.55%
IN:SUDARSCHEM
Sudarshan Chemical Industries Limited
1,241.55
-173.67
-12.27%

Fineotex Chemical Limited Corporate Events

Fineotex Forms U.S. Step-Down Subsidiary to Drive Specialty Chemicals Expansion
Sep 1, 2026
Fineotex Chemical Limited has expanded its global structure by incorporating a wholly owned step-down subsidiary, Fineotex Holdings Inc., in the U.S. state of Delaware through its existing subsidiary Fineotex Biotex HealthGuard FZE. The new entity...
Fineotex Chemical Publishes Q1 FY2026-27 Investor Presentation
Jul 23, 2026
Fineotex Chemical Limited has submitted its investor presentation for the first quarter of FY2026-27 to the Bombay Stock Exchange and the National Stock Exchange, in line with SEBI’s listing and disclosure regulations. The presentation, deta...
Fineotex Chemical to Join ULJK Virtual Investor Meet on June 24
Jun 19, 2026
Fineotex Chemical Limited has announced that its management will participate in a group virtual investor and analyst conference organized by ULJK on Wednesday, June 24, 2026, at 3:30 p.m. IST. The company has clarified that no unpublished price-se...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 08, 2026